Match tier Listed
Presence Current · Arkansas
Last published 2026
Sources OpenAlex · ORCID
Refreshed 2026-10-01

Munes Albadaineh

Role not yet determined Is this you? Add your title

Also affiliated: King Abdullah Medical City (2013–2014)

4 h-index 6 pubs 91 cited

  • Humans
  • Treatment Outcome
  • Myocardial Infarction
  • Percutaneous Coronary Intervention
  • Anti-Infective Agents
  • Drug Interactions
  • Methotrexate
  • Trimethoprim, Sulfamethoxazole Drug Combination
  • Antirheumatic Agents
  • Antineoplastic Agents
  • Gastrointestinal Neoplasms
  • Infusions, Parenteral
  • Injections, Intraperitoneal
  • Medication Errors
  • Peritoneal Neoplasms

Biography and Research Information

OverviewAI-generated summary

Munes Albadaineh's research has focused on pharmacologic interactions and clinical applications of various agents. Publications include work on the potentially life-threatening combination of methotrexate and trimethoprim-sulfamethoxazole, practical considerations for high-dose methotrexate therapy, and the role of oncology clinical pharmacists in patient care. Albadaineh has also investigated intraperitoneal chemotherapy and reviewed the literature on percutaneous pericardiocentesis. More recent work explores the safety and efficacy of enoxaparin in percutaneous coronary intervention, cardiovascular outcomes associated with SGLT2 inhibitor and GLP1 receptor agonist therapy in type 2 diabetes, and trends in interventional cardiology fellowship positions.

With an h-index of 4 and 91 total citations across 6 publications, Albadaineh has collaborated with researchers at the University of Arkansas for Medical Sciences, including Malek Alaiwah, Omar Alqaisi, Robert Spraggins, and Landon Bruich, with whom multiple shared publications exist. Albadaineh's scholarship metrics indicate recent activity, with publications extending to 2026.

Metrics

  • h-index: 4
  • Publications: 6
  • Citations: 91

Selected Publications

  • The Growing Concern of Unfilled Interventional Cardiology Fellowships: Causes, Trends, and the Path Forward (2026)
    Journal of the Society for Cardiovascular Angiography & Interventions DOI OpenAlex
  • 26-A-11242-ACC REAL-WORLD CARDIOVASCULAR OUTCOMES OF COMBINED SGLT2 INHIBITOR AND GLP1 RECEPTOR AGONIST THERAPY IN TYPE 2 DIABETES INDIVIDUALS (2026)
    Journal of the American College of Cardiology DOI OpenAlex
  • Prevalence and Most Commonly Encountered QRS Fragmentation Morphology and Early Repolarization ST-Segment Changes During the Height of the COVID-19 Pandemic: A Single-Center Experience (2026)
    Cureus DOI OpenAlex
  • Left Ventricular Apical Long-Axis Length and Ejection Fraction: A Proof-of-Concept Analysis (2025)
  • Improving Recognition of Heart Failure With Preserved Ejection Fraction in the Outpatient Setting: A Pilot Study of Readily Useful Clinical Attributes (2025)
  • HYPERTENSIVE RESPONSE DURING DOBUTAMINE STRESS ECHOCARDIOGRAPHY AND RISK OF NEW ONSET HEART FAILURE (2025)
  • SIGNIFICANCE OF ISCHEMIC ELECTROCARDIOGRAM CHANGES IN THE SETTING OF NORMAL IMAGING IN DOBUTAMINE STRESS ECHOCARDIOGRAPHY (2025)
  • Percutaneous pericardiocentesis using the apical approach: case series and review of the literature (2024)
    The Egyptian Heart Journal 2 citations DOI OpenAlex
  • Safety and Efficacy of Enoxaparin During Percutaneous Coronary Intervention (2024)
    Cardiovascular revascularization medicine DOI OpenAlex
  • Safety and Efficacy of Enoxaparin During Low-Risk Elective Percutaneous Coronary Intervention (2024)
    The American Journal of Cardiology 2 citations DOI OpenAlex
  • 100.51 Safety and Efficacy of Enoxaparin During Percutaneous Coronary Intervention (2024)
    JACC: Cardiovascular Interventions DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

47 Collaborators 14 Institutions 3 Countries

Top Collaborators

View profile →
View profile →
View profile →
View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics